Answers are grounded in this paper and cite their sources.
// Mohamed-Amine Hamouda 1,2,3 , Nathalie Belhacene 1,2,3 , Alexandre Puissant 4 , Pascal Colosetti 1,2,3 , Guillaume Robert 1,2,3 , Arnaud Jacquel 1,2,3 , Bernard Mari 5 , Patrick Auberger 1,2,3,* and Frederic Luciano 1,2,3,* 1 INSERM U1065, C3M, Team 2, Nice, France 2 Université de Nice Sophia-Antipolis 3 Equipe labellisée par la Ligue Nationale Contre le Cancer 4 Dana-Farber Cancer Institute and Boston Children’s Hospital, Harvard Medical School, Boston, USA 5 UMR7275 CNRS-UNS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France * These authors contributed equally to this work Correspondence: Frederic Luciano, email: // Keywords : multiple myeloma, velcade, resistance, HSPB8, aggregates, autophagy Received : May 13, 2014 Accepted : July 8, 2014 Published : July 9, 2014 Abstract Velcade is one of the inescapable drug to treat patient suffering from multiple myeloma (MM) and resistance to this drug represents a major drawback for patients. However, the mechanisms underlying velcade resistance remain incompletely understood. We derived several U266 MM cell clones that resist to velcade. U266-resistant cells were resistant to velcade-induced cell death but exhibited a similar sensitivity to various proapoptotic stimuli. Careful analysis of proteosomal subunits and proteasome enzymatic activities showed that neither the composition nor the activity of the proteasome was affected in velcade-resistant cells. Elimination of velcade-induced poly-ubiquitinated proteins and protein aggregates was drastically stimulated in the resistant cells and correlated with increased cell survival. Inhibition of the lysosomal activity in velcade-resistant cells resulted in an increase of cell aggregates and decrease survival, indicating that aggregates are eliminated through lysosomal degradation. In addition, pangenomic profiling of velcade-sensitive and resistant cells showed that the small heat shock protein HSPB8 was overexpressed in resistant cells. Finally, gain and loss of function experiment demonstrated that HSPB8 is a key factor for velcade resistance. In conclusion, HSPB8 plays an important role for the elimination of aggregates in velcade-resistant cells that contributes to their enhanced survival.
No takes yet. Share an insight, caveat, or question.
Hamouda et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: